<VariationArchive VariationID="648191" VariationName="NM_152490.5(B3GALNT2):c.699del (p.Val234fs)" VariationType="Deletion" Accession="VCV000648191" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="627443" VariationID="648191">
      <GeneList>
        <Gene Symbol="B3GALNT2" FullName="beta-1,3-N-acetylgalactosaminyltransferase 2" GeneID="148789" HGNC_ID="HGNC:28596" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235439796" stop="235504452" display_start="235439796" display_stop="235504452" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_014040927.1" start="83388" stop="148044" display_start="83388" display_stop="148044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235610532" stop="235667780" display_start="235610532" display_stop="235667780" Strand="-" />
          </Location>
          <OMIM>610194</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152490.5(B3GALNT2):c.699del (p.Val234fs)</Name>
      <CanonicalSPDI>NC_000001.11:235470912:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235470913" stop="235470913" display_start="235470913" display_stop="235470913" variantLength="1" positionVCF="235470912" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235634227" stop="235634227" display_start="235634227" display_stop="235634227" variantLength="1" positionVCF="235634226" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V234fs</ProteinChange>
      <ProteinChange>V275fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.235634228del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.235634228del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.235470914del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.235470914del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033219.2" sequenceAccession="NG_033219" sequenceVersion="2" change="g.38569del">
            <Expression>NG_033219.2:g.38569del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001277155.3" sequenceAccession="NM_001277155" sequenceVersion="3" change="c.822del">
            <Expression>NM_001277155.3:c.822del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264084.1" sequenceAccession="NP_001264084" sequenceVersion="1" change="p.Val275fs">
            <Expression>NP_001264084.1:p.Val275fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152490.5" sequenceAccession="NM_152490" sequenceVersion="5" change="c.699del" MANESelect="true">
            <Expression>NM_152490.5:c.699del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689703.1" sequenceAccession="NP_689703" sequenceVersion="1" change="p.Val234fs">
            <Expression>NP_689703.1:p.Val234fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152490.4" sequenceAccession="NM_152490" sequenceVersion="4" change="c.699delT">
            <Expression>NM_152490.4:c.699delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1572513308" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152490.5(B3GALNT2):c.699del (p.Val234fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" Accession="RCV000802859" Version="3">
        <ClassifiedConditionList TraitSetID="9507">
          <ClassifiedCondition DB="MedGen" ID="C3554638">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23453667</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17747" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ElementValue>
                <XRef ID="MONDO:0014071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A11</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA11</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15915" />
                <XRef ID="15915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3554638" DB="MedGen" />
              <XRef ID="MONDO:0014071" DB="MONDO" />
              <XRef Type="MIM" ID="615181" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1836673" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5210583|MedGen:C3554638" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000942705" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23453667</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 648191). This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val234Cysfs*8) in the B3GALNT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in B3GALNT2 are known to be pathogenic (PMID: 23453667).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.235634227del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554638" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1836673" TraitType="Disease" MappingType="XRef" MappingValue="C3554638" MappingRef="MedGen">
        <MedGen CUI="C3554638" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

